Cisplatin is an effective chemotherapeutic agent used in the treatment of many pediatric solid tumors. Retinal toxicity is a side effect of the drug reported in adults, but is not well described in pediatric patients. We present the cases of two children treated with cisplatin and etoposide who expe
Treatment with cisplatin and etoposide in patients with neuroendocrine tumors
✍ Scribed by Marie-Louise H. Fjällskog; Dan. P. K. Granberg; Staffan L. V. Welin; Christopher Eriksson; Kjell E. Öberg; Eva T. Janson; Barbro K. Eriksson
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 79 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The authors thank the Italian Trials in Medical Oncology (I.T.M.O.) group for their assistance with statistical analysis and preparation of the manuscript.
A 61-year-old woman underwent a left radical nephrectomy for Stage I1 anaplastic Wilms' tumor. She received no adjuvant therapy. One year later computerized tomography (CT) of the abdomen revealed a mass in the left renal fossa and retroperitoneal adenopathy. A CT-guided needle biopsy was nondiagnos
## BACKGROUND. Patients with neuroendocrine gastrointestinal tumors usually present with inoperable metastatic disease and severe hormonal symptoms. Specific chemotherapy, interferon-␣ (IFN), and somatostatin analogs are established therapies for these patients, but all of them eventually fail. Hep
BACKGROUND. The use of either mitotane or chemotherapy in the treatment of advanced adrenocortical carcinoma (ACC) has led to scanty and controversial results. The recent finding that mitotane is able to reverse in vitro multidrug resistance has provided a rational basis for combining this agent wit